As of 2026-09-15, the Fair Value of Madrigal Pharmaceuticals Inc (MDGL) is -70.49 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 540.06 USD, the upside of Madrigal Pharmaceuticals Inc is -113.05%.
With the market price of 540.06 USD and our fair value calculation, Madrigal Pharmaceuticals Inc (MDGL) is not a good investment. Investing in MDGL stocks now will result in a potential loss of 113.05%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | 5Y Avg | |
| Net income | -241.80 | -295.40 | -373.63 | -465.89 | -288.28 | -333.00 |
| YoY growth | -19.58% | -22.17% | -26.48% | -24.69% | 38.12% | -10.96% |
| Market Cap (mil) | 12,453.78 |
| P/E | |
| Forward P/E |
| EPS | -14.10 |
| Avg earnings growth rate | -10.96% |
| TTM earnings | -325.10 |